Cytori Begins Breast Reconstruction Study in Europe.

Business WireMay 01, 2008

Linked as:

Extract


Cytori Begins Breast Reconstruction Study in Europe.

SAN DIEGO -- Cytori (NASDAQ:CYTX) received approval to begin its European stem and regenerative cell-enhanced breast reconstruction study in breast cancer patients who have undergone partial mastectomy. This is a post-market study designated as RESTORE II. C...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company